P/Q-type calcium channel modulators. - Test2 - elhamkhani - TriplyDB

P/Q-type calcium channel modulators.

P/Q-type calcium channel modulators.

http://www.wikidata.org/entity/Q38016449

about

Intrinsic electrical properties of mammalian neurons and CNS function: a historical perspective Introgression and selection shaped the evolutionary history of sympatric sister-species of coral reef fishes (genus: Haemulon).Inhibition of A-type potassium current by the peptide toxin SNX-482 Spinal blockage of P/Q- or N-type voltage-gated calcium channels modulates functional and symptomatic changes related to haemorrhagic cystitis in mice.Recent patents on calcium channel blockers: emphasis on CNS diseases.Voltage-Induced Ca²⁺ Release in Postganglionic Sympathetic Neurons in Adult Mice.Calcium Channels and Associated Receptors in Malignant Brain Tumor Therapy.Signalling pathways involved in the detection of peptones by murine small intestinal enteroendocrine L-cells The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.Differential effects of voltage-gated calcium channel blockers on calcium channel alpha-2-delta-1 subunit protein-mediated nociception The Neuroglial Dialog Between Cannabinoids and Hemichannels.Differential regulation of nimodipine-sensitive and -insensitive Ca2+ influx by the Na+/Ca2+ exchanger and mitochondria in the rat suprachiasmatic nucleus neurons.Short-Term Plasticity at Olfactory Cortex to Granule Cell Synapses Requires Ca2.1 Activation

P2860

Q21129472-9EB8B63D-3530-4E89-9D7E-CABDABCD1C68 Q30571973-7D6E6C60-7C6D-4659-8500-93BD143A7EA3 Q33865281-EC932ED9-9478-41BC-8681-77E9B1B1A939 Q34994554-4DA607AF-A0ED-47F3-92E9-780A1A77B058 Q38239508-3AE3E5F7-C0E9-43DB-9409-154EC541E814 Q38317873-8DF8BE9B-57B0-4832-AAB2-D6C9B81626DF Q38897530-C6FBE424-5AAB-489D-9305-9FB4EED1B3BB Q38947253-D9D404CC-E4D4-469D-A4A6-8AEAEC8969C4 Q39181842-A6DB919B-330F-49AB-A4B4-B411A7E25C56 Q41902234-CE8C53BB-891A-4BF0-90A7-1E0629BD9E18 Q53829696-0AC12DB4-34B3-4EA5-96D6-D7C13286CFE1 Q55297652-E9212F48-A3DA-4E3D-832A-8993E17118F1 Q58707424-E581E4DE-1257-4EEC-9419-55811EBCD20C

P2860

P/Q-type calcium channel modulators.

http://www.wikidata.org/entity/Q38016449

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

P/Q-type calcium channel modulators.

@en

type

label

P/Q-type calcium channel modulators.

@en

prefLabel

P/Q-type calcium channel modulators.

@en

P1433

Q38016449-EFE9A4C9-53C7-40E5-BFFD-F02E73336F09

P1476

Q38016449-75F4D291-5190-4AC3-8A78-0B3132F6CC41

P2093

Q38016449-0269E7DB-2C26-4760-9DB6-4DE1F8BD9A4F

Q38016449-40E7F3D5-E04F-40C1-BB76-4B1595A8A241

P2860

Q38016449-03211E3B-7903-4419-BB29-E2C41B6D89E8

Q38016449-03A53FA7-8C6F-441D-98E8-BFCD6619C756

Q38016449-058CC6E7-2836-49B7-B82E-95246DE6B2D8

Q38016449-060F3C9E-37E9-441E-AACB-95474BB75A82

Q38016449-0621CE40-ED36-4B2F-8109-B77AD7AD9546

Q38016449-06A00AFA-91F5-4EFD-9E8D-2E6CCD5873B6

Q38016449-07579818-D393-4743-8D3E-4EB4379C7FDF

Q38016449-07C8EF13-7549-45B5-BB97-1FF58F118421

Q38016449-0A891701-84F3-4A32-A4C7-75F3F30BB2E5

Q38016449-0AB92322-1A62-41AA-953D-828F53F465F2

P304

Q38016449-1EC71E9B-8E39-4575-9907-5976F64C2362

P31

Q38016449-1B4DEF9E-4D30-4B4A-A741-2BB75FEBEE55

P356

Q38016449-6E70D207-9B69-420B-9CB6-2B98080C352F

P407

Q38016449-5A76B739-8D84-47DA-AFF7-DF7F1E5F8842

P433

Q38016449-C8BF0D5A-D3B5-4BD8-857E-9E96F6025344

P478

Q38016449-F41B8A32-2E51-4779-B7B1-EEF708813A11

P577

Q38016449-0A26F57C-F749-4112-83EA-DF6B57594971

P5875

Q38016449-5F1FA016-2018-4060-982F-E00A29D5300B

P698

Q38016449-711DA4F7-7D03-46A4-8222-D73A62C91FDC

P932

Q38016449-A3CD0C8A-A7C9-4670-9EC0-BFB0081A42D0

P356

J.1476-5381.2012.02069.X

P1433

British Journal of Pharmacology

P1476

P/Q-type calcium channel modulators.

@en

P2093

G Gross

http://www.w3.org/2001/XMLSchema#string

V Nimmrich

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic identification of splice variants in human P/Q-type channel alpha1(2.1) subunits: implications for current density and Ca2+-dependent inactivation

Structural elements in domain IV that influence biophysical and pharmacological properties of human alpha1A-containing high-voltage-activated calcium channels.

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Calcicludine, a venom peptide of the Kunitz-type protease inhibitor family, is a potent blocker of high-threshold Ca2+ channels with a high affinity for L-type channels in cerebellar granule neurons

Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors

Mechanisms of migraine aura revealed by functional MRI in human visual cortex

Conus venom peptide pharmacology

Structure-activity relationships of omega-conotoxins MVIIA, MVIIC and 14 loop splice hybrids at N and P/Q-type calcium channels

Solution structure of omega-grammotoxin SIA, a gating modifier of P/Q and N-type Ca(2+) channel

Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers

P304

741-759

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2012.02069.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225274811

http://www.w3.org/2001/XMLSchema#string

P698

22670568

http://www.w3.org/2001/XMLSchema#string

P932

3575775

http://www.w3.org/2001/XMLSchema#string